In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Merck KGAA grosses €1bn through capital increase

Executive Summary

Majority shareholder E. Merck OHG and other existing investors purchased 13.3mm new shares of Merck KGAA for €78 ($101) per share (an 11% discount), providing proceeds of €1.03bn to the company. The capital increase was pursued in part to finance Merck's recent acquisition of Serono.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Other

Related Companies